Main Menu - Harvard Catalyst Main Menu – Harvard Catalyst
Related Programs & Initiatives Program Icon

Following are Harvard-affiliated programs and initiatives conducting or supporting multi-disciplinary research:

The Broad Institute of MIT and Harvard
A unique scientific community of diverse talents but singular purpose, the Broad Institute brings together world-class faculty, professional staff, and students from throughout the MIT and Harvard communities and beyond, empowering them to work together to identify and overcome the most critical obstacles to realizing the full promise of genomic medicine.
Center for Integration of Medicine and Innovative Technology (CIMIT)
A non-profit consortium of Boston teaching hospitals and engineering schools, CIMIT fosters interdisciplinary collaboration among world-class experts in medicine, science and engineering, in concert with industry and government, to rapidly improve patient care.
Dana-Farber Harvard Cancer Center (DF/HCC)
Dana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, and Massachusetts General Hospital. Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal - to find new and innovative ways to combat cancer.
The eagle-i Consortium
The eagle-i Consortium, made up of nine member institutions across the U.S., has built a research resource discovery platform to help biomedical scientists search for and find highly valuable resources. Access to search tens of thousands of biomedical research resources from Harvard and other participating institutions is available with free registration at
The Football Players Health Study at Harvard University
The Football Players Health Study at Harvard University seeks to improve the health and wellbeing of former NFL players, while furthering our understanding of the benefits and risks of participation in American football.
Harvard Institute for Global Health (HIGH)
The Harvard Institute for Global Health (HIGH) is a university-wide initiative whose mission is to educate and train the next generation of global health leaders, and create and disseminate new knowledge to address the major challenges in global health.
Harvard Interfaculty Initiative on Medications and Society
The Harvard Interfaculty Initiative on Medications and Society is a collaborative effort to bring together faculty and students across all Departments and Schools of Harvard University who share an interest in how prescription drugs are developed, approved, regulated, and paid for; as well as how they are prescribed, viewed, and taken by patients.
Harvard Stem Cell Institute (HSCI)
The Harvard Stem Cell Institute (HSCI) is a scientific collaborative established to investigate the complex biology and therapeutic potential of stem cells. With over 200 faculty members at Harvard and its 11 affiliated hospitals, HSCI supports cutting-edge science through sponsoring research projects, operating core facilities, managing events, and offering training opportunities.
News on all matters related to science at the various schools, departments, institutes, and hospitals of Harvard University.
HMS Center for Primary Care
The Harvard Medical School (HMS) Center for Primary Care focuses on four program areas: education, innovation, community-building, and leadership development. The Center is creating a vibrant community to transform care by embracing service, wellness, patient and community empowerment, and innovation in systems for care and training at Harvard, academic health centers, and beyond.
HMS Department of Biomedical Informatics (DBMI)
The Harvard Medical School (HMS) Department of Biomedical Informatics (DBMI) is a research center within the Harvard Medical School that promotes and facilitates collaborative activities in biomedical informatics among researchers at Harvard Medical School and its affiliated institutions. In an era of biomedical knowledge overload, high-throughput biomedical data generation, increasing consumer access to biomedical information, and demands for real-time, information based public health, the DBMI was established to lead research and educational activities to meet these pressing national needs.
HMS Portugal Program in Translational Research and Information
In April 2007, the Portuguese Ministry of Science, Technology and Higher Education signed a Memorandum of Understanding with Harvard Medical School to identify the potential for cooperation with this medical school. The goal was to develop and streamline a program with the aim of encouraging internationalization and cooperation between Portuguese schools of medicine and major national research centers working in biomedical and health sciences.
The Kavli Institute for Bionano Science and Technology at Harvard (KIBST)
The Kavli Institute for Bionano Science and Technology (KIBST) seeks to develop a deeper understanding of the functioning of life and biology at the nanoscale level. The Institute: brings together a wide range of scientists, including physicists, engineers, chemists, biologists as well as HMS clinicians to address fundamental questions about the behavior and functioning of biological systems; allows biologists, engineers, and clinicians to potentially use such knowledge to foster applications and new technologies; and provides a way for the tool-developers (physicists, engineers, computer scientists) to work with the tool-users (biologists, chemists, clinicians) in the early stages of scientific inquiry and encourage scientific collaboration at the innovation stage of tool development.
Microbial Sciences Initiative
The Microbial Sciences Initiative (MSI) at Harvard is an interdisciplinary science program aimed at a comprehensive understanding of the richest biological reservoir of the planet, the microbial world.
The Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics
The Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics is an interdisciplinary program at Harvard Law School dedicated to the scholarly research of important issues at the intersection of law and health policy. From healthcare financing and market regulation to biomedical research and bioethics, the Petrie-Flom Center seeks to bring new vision to the complex healthcare challenges that face our society.
Radcliffe Institute for Advanced Study
The Radcliffe Institute for Advanced Study at Harvard University is a scholarly community where individuals pursue advanced work across a wide range of academic disciplines, professions, and creative arts. Within this broad purpose, the Radcliffe Institute sustains a continuing commitment to the study of women, gender, and society.
Harvard Catalyst, in collaboration with Dartmouth Synergy and University of Wisconsin-Madison, has launched SMART IRB, a national platform designed to streamline and harmonize the IRB review process for multisite research, while ensuring a high level of protection for research participants. SMART IRB is intended to serve as a roadmap for institutions to implement The National Institutes of Health (NIH) Policy on the Use of a Single Institutional Review Board for Multi-Site Research. SMART IRB began as a project called IRBrely, which was led by Dartmouth College and funded by the National Center for Advancing Translational Science (NCATS) from September 2014 through April 2016. This collaborative effort built upon existing regional networks for IRB reliance to develop a master IRB reliance agreement and standard operating procedures (SOPs) suitable for use across the nation. In July 2016, NCATS funded the next phase of work to enable IRB reliance on a national scale.
The Wyss Institute for Biologically Inspired Engineering
The Wyss Institute for Biologically Inspired Engineering uses Nature's design principles to create breakthrough technologies that will revolutionize medicine, industry, and the environment. Working as an alliance among Harvard University, other academic institutions, hospitals, and industry, the Institute crosses disciplinary and institutional barriers to engage in high-risk, fundamental research that leads to transformative change. By applying biological principles, Wyss researchers are developing innovative new engineering solutions for healthcare, manufacturing, robotics, energy, and sustainable architecture. These technologies are translated into commercial products and therapies through collaborations with clinical investigators, corporate alliances, and new startups.
Footer - Harvard Catalyst Footer – Harvard Catalyst